Chronic cerebral ischemia: potential for Vasobral use
Increase in the number of patients with acute and chronic ischemic cerebrovascular disturbances determines the relevance of the problem of their effective treatment. Recently, special attention is paid to the combined drugs with neuroprotective, antihypoxic and vasoactive effects. The article discusses the main pathogenetic aspects of the drug Vazobral (digidroergokriptin + caffeine) efficacy in insufficiency of cerebral circulation; the results of clinical trials of this drug in the treatment of patients with cerebrovascular diseases are presented.

Keywords: Vazobral, cerebrovascular insufficiency, cerebral ischemia, apoptosis